1266684-01-8

1266684-01-8 structure

Name: FIDAS-3
Chemical Name: FIDAS-3
CAS Number: 1266684-01-8
Molecular Formula: C₁₆H₁₅F₂N
Molecular Weight: 259.29
Catalog: Signaling Pathways Stem Cell/Wnt Wnt
Create Date: 2020-06-01 08:47:08
Modify Date: 2024-01-13 17:09:40
FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A). FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-3 has anticancer activities[1][2].

Name	FIDAS-3

Description	FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A). FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-3 has anticancer activities[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Stem Cell/Wnt >> Wnt
Target	IC50: 4.9 μM (Methionine S-adenosyltransferase 2A (MAT2A))[1]
In Vitro	FIDAS-3 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells[1]. FIDAS-3 (3-10 μM) treatment inhibits the expression of c-Myc and cyclinD1 in LS174T CRC cells. And FIDAS-3 induces the expression of cell cycle inhibitor, p21WAF1/CIP1[1]. FIDAS-3 (10 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells[1]. Cell Viability Assay[1] Cell Line: LS174T colorectal cancer (CRC) cells Concentration: 3 μM Incubation Time: 7 days Result: Significantly inhibited the proliferation of LS174T cells.
In Vivo	FIDAS-3 (20 mg/kg; intraperitoneal injection; daily; for one months; C57BL/6J athymic nude mice) treatment significantly inhibits the growth of xenograft tumors[2]. Animal Model: C57BL/6J athymic nude mice (6-8 week) injected with LS174 cells[2] Dosage: 20 mg/kg Administration: Intraperitoneal injection; daily; for one months Result: Significantly inhibited the growth of xenograft tumors.
References	[1]. Zhang W, et al. Fluorinated N,N-dialkylaminostilbenes repress colon cancer by targeting methionine S-adenosyltransferase 2A. ACS Chem Biol. 2013 Apr 19;8(4):796-803. [2]. Zhang W, et al. Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression. J Med Chem. 2011 Mar 10;54(5):1288-97.

Molecular Formula	C₁₆H₁₅F₂N
Molecular Weight	259.29

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1266684-01-8	141087-33-4
64395-07-9	1227579-00-1
92878-95-0	1256360-08-3
110966-11-5	873077-21-5
11096-09-6	107215-52-1
946219-21-2	903262-62-4
897481-25-3	897481-37-7
897481-69-5	946325-73-1
887220-16-8	946373-51-9
887220-20-4	946219-25-6